These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36441403)

  • 21. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
    Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
    Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination.
    Kim IC; Kim H; Lee HJ; Kim JY; Kim JY
    J Korean Med Sci; 2021 Aug; 36(32):e229. PubMed ID: 34402228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.
    Lane S; Yeomans A; Shakir S
    BMJ Open; 2022 May; 12(5):e059223. PubMed ID: 35613761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination.
    Piché-Renaud PP; Morris SK; Top KA
    Br J Clin Pharmacol; 2023 Mar; 89(3):967-981. PubMed ID: 36480113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).
    Fix J; Christopher Mast T; Smith K; Baker N
    Vaccine; 2024 Apr; 42(9):2161-2165. PubMed ID: 38494410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis.
    Chou OHI; Mui J; Chung CT; Radford D; Ranjithkumar S; Evbayekha E; Nam R; Pay L; Satti DI; Garcia-Zamora S; Bazoukis G; Çinier G; Lee S; Vassiliou VS; Liu T; Tse G; Wong ICK; ; Chou OHI; Liu T; Tse G
    Clin Res Cardiol; 2022 Oct; 111(10):1161-1173. PubMed ID: 35906423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 vaccines and myocarditis.
    Sularz AK; Hua A; Ismail T
    Clin Med (Lond); 2023 Sep; 23(5):495-502. PubMed ID: 37775180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, Clinical Presentation, and Management of Myocarditis following mRNA-Based Covid-19 Vaccines: A Brief Report.
    Saeed S; Käsk L; Rajani R; Larsen TH
    Cardiology; 2022; 147(4):406-412. PubMed ID: 35104821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
    Lee S; Jo H; Lee H; Lee H; Lee J; Kim HJ; Kang J; Jacob L; Smith L; Rahmati M; López Sánchez GF; Dragioti E; Jeon H; Cho JM; Choi Y; Park J; Woo S; Yon DK
    J Med Virol; 2024 Jun; 96(6):e29693. PubMed ID: 38859751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis.
    Hadley SM; Prakash A; Baker AL; de Ferranti SD; Newburger JW; Friedman KG; Dionne A
    Eur J Pediatr; 2022 Jul; 181(7):2879-2883. PubMed ID: 35482094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocarditis and pericarditis after COVID-19 messenger RNA vaccines.
    Goldman RD
    Can Fam Physician; 2022 Jan; 68(1):17-18. PubMed ID: 35063975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
    Naveed Z; Li J; Wilton J; Spencer M; Naus M; Velásquez García HA; Kwong JC; Rose C; Otterstatter M; Janjua NZ;
    J Am Coll Cardiol; 2022 Nov; 80(20):1900-1908. PubMed ID: 36357091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.
    Hatziantoniou S; Anastassopoulou C; Lazaros G; Vasileiou K; Tsioufis C; Tsakris A
    Expert Rev Vaccines; 2022 Nov; 21(11):1691-1696. PubMed ID: 35815358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department presentations for chest complaints after mRNA COVID-19 vaccinations in children and adolescents.
    Parr M; Wilson CL; Jones B; Crawford NW; Ferguson S; Ramesh S; Eapen N; Craig S; Hearps S; Babl FE;
    Emerg Med Australas; 2024 Feb; 36(1):110-117. PubMed ID: 37872323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination.
    Sánchez Tijmes F; Marschner CA; de Matos JFRG; Urzua Fresno CM; Gutiérrez Chacoff JM; Thavendiranathan P; Fuss C; Hanneman K
    Radiographics; 2023 Sep; 43(9):e230044. PubMed ID: 37616171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of COVID-19 vaccination and the reported cardiac manifestations.
    Ho JSY; Sia CH; Ngiam JN; Loh PH; Chew NWS; Kong WK; Poh KK
    Singapore Med J; 2023 Sep; 64(9):543-549. PubMed ID: 34808708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.